T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes

Journal of Clinical Immunology

Volumn 19, Issue 2, 1999, Pages 127-134

  Dubois LaForgue, Danièle ^a,b   Carel, Jean Claude ^a   Bougnères, Pierre François ^a   Guillet, Jean Gérard ^c   Boitard, Christian ^a,b  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Institut Cochin   (France)

Author keywords

Antiinsulin antibodies; Insulin; Proinsulin; T cell response; Type 1 diabetes

Indexed keywords

INSULIN; INSULIN ANTIBODY; PROINSULIN;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE;

EID: 0032928167     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020558601175     Document Type: Article

References (52)

1. 1. Gepts W, Lecompte PM: The pancreatic islet in diabetes. Am J Med 70:105-115, 1981
2. 2. Kay TW, Campbell IL, Harrison LC: Characterisation of pancreatic T lymphocytes associated with beta cell destruction in the non obese diabetic (NOD) mouse. J Autoimmun 4:263-266, 1991
3. 3. Bendelac A, Carnaud C, Boitard C, Bach JF: Syngenic transfert of autoimmune diabetes from diabetic NOD mice to healthy neonate. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med 166:823-832, 1987
4. 4. Haskins K, MacDuffie M: Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249:1433-1436, 1990
5. 5. Koevary S, Rossini AA, Stoller W, Chick W, Williams RM: Passive transfert of diabetes mellitus in the BB/W rat. Science 206:1421-1423, 1983
6. adonors. Diabetes 42:44-55, 1993
7. 7. Stiller CR, Dupre J, Gent M, Jenner MR, Keown PA, Laupacis A, Martell R, Rodger NW, von Graffenfried B, Wolfe BMJ: Effects of cyclosporin immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223:1362-1367, 1984
8. 8. Atkinson MA, Maclaren NK: Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest 92:1608-1616, 1993
9. 9. Baekkeskov S, Aanstoot HJ, Christgrau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthezing enzyme glutamic acid decarboxylase. Nature (Lond) 347:151-156, 1990
10. 10. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37,000-and 40,000-Mr fragments of islet antigens in insulin-dependent diabetes to the protein tyrosin phosphatase-like molecule IA-2 (ICA512). J Clin Invest 95:1506-1511, 1995
11. 11. Aanstoot HJ, Kang SM, Kim J, Lindsay L, Roll U, Knip M, Atkinson M, Mose-Larsen P, Fey S, Ludvigsson J, Landin M, Bruining J, Maclaren NK, Akerblom HK, Baekkeskov S: Identification and characterization of Glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest 97:2772-2783, 1996
12. 12. Castano L, Eisenbarth GS: Type-I diabetes: A chronic autoimmune disease of human, mouse and rat. Ann Rev Immunol 8:647-679, 1990
13. 13. Bonifacio E, Bingley P, Shattock PM, Dean BM, Dunger D, Gale EAM, Botazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147-149, 1990
14. 14. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Botazzo GF, Gale E: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310, 1994
15. 15. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
16. 16. Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, Dyrberg T, Akerblom HK, Knip M, and the Childhood Diabetes in Finland Study Group: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. J Clin Invest 101:327-336, 1998
17. 17. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337-1339, 1983
18. 18. Kuglin B, Gries FA, Kolb H: Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes 37:130-132, 1988
19. 19. Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS: Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type 1 diabetes. Diabetes 38:1320-1325, 1989
20. 20. Keller RJ: Cellular immunity to human insulin in individuals at high risk for the development of type 1 diabetes mellitus. J Autoimmun 3:321-327, 1990
21. 21. Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, Eisenbarth GS: Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 40:564-572, 1997
22. 22. Harrison LC, Chu SX, De Aizpurua HJ, Graham M, Honeyman MC, Colman PG: Islet reactive T cells are a marker of preclinical insulin-dependent diabetes. J Clin Invest 89:1161-1165, 1991
23. 23. Harrison LC, De Aizpurua H, Loudovaris T, Campbell IL, Cebon JS, Tait BD, Colman PG: Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 40: 1128-1133, 1991
24. 24. Rudy G, Stone N, Harrison LC, Colman PG, McNair P, Brusic V, French MB, Honeyman MC, Tait B, Lew AM: Similar peptides from two β cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med 1:625-634, 1995
25. 25. Caillat-Zucmann S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali-Saiah I, Bougnères P, Bach JF: Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 90:2242-2250, 1992
26. 26. Boitard C, Bonifacio E, Botazzo GF, Gleichmann H, Molenaar J: Immunology and Diabetes Workshop: Report on the third international (stage 3) workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 31:451-452, 1988
27. 27. Castano L, Boitard C, Bougnères PF: Cyclosporin A supresses insulin autoantibodies and heterologous insulin antibodies in type 1 diabetic children. Diabetes 37:1049-1052, 1988
28. 28. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T: Detection of GAD 65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459-467, 1994
29. 29. Kawasaki E, Yu L, Gianani R, Verge CF, Babu S, Bonifacio E, Eisenbarth GS: Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs. J Clin Endocrinol Metab 82:375-380, 1997
30. 30. Atkinson MA, Kaufmann DL, Cambell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, MacLaren NK: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458-459, 1992
31. 31. Arden SD, Roep BO, Neophytou PI, Usac EF, Duinkerken G, de Vries RP: Imogen 38: A novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type I patient. J Clin Invest 97:551-561, 1996
32. 32. Durinovic-Bello I, Hummel M, Ziegler AG: Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45:795-800, 1996
33. 33. Ellis TM, Schatz DA, Ottendorfer EW, Lan MS, Wasserfall C, Salisbury PJ, She JX, Notkins AL, Maclaren NK, Atkinson MA: The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes 47:566-569, 1998
34. 34. Rouas N, Christophe S, Housseau F, Bellet D, Guillet JG, Bidart JM: Influence of protein-quaternary structure on antigen processing. J Immunol 150:782-792, 1993
35. 35. Vacchio MS, Berzovsky JA, Krzych U, Smith JA, Hodes RJ, Finnegan A: Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones. J Immunol 143:2814-2819, 1989
36. 36. Zhuoru L, Williams KP Chang YH, Smith JA: Single aminoacid substitution alters T cell determinant selection during antigen processing of Staphylococcus aureus nuclease. J Immunol 146: 438-443, 1991
37. 37. Del Val M, Schlicht HJ, Ruppert T, Reddehase MJ, Koszinovski UH: Efficient processing of an antigenic sequence for presentation by MHC class 1 molecules depends on its neighboring residues in the protein. Cell 66:1145-1153, 1991
38. 38. Ellis TM, Darrow B, Campbell L, Atkinson MA: Inverse relationship between humoral and cellular immune responses to glutamate decarboxylase 65 (GAD) and insulín in IDD. Diabetes 44 (Suppl 1):52A, 1995
39. 39. Harrison LC, Honeyman M, De Aizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365-1369, 1993
40. 40. Romagnani S: TH1 and TH2 in human diseases. Clin Immunol Immunopathol 80:225-235, 1996
41. 41. Tian J, Kaufman DL: Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice. Diabetologia 41:237-240, 1998
42. 42. Diaz JL, Wilkin T: Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA). Diabetes 36:66-72, 1987
43. 43. Paliard X, SG West, Lafferty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL: Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253:325-329, 1991
44. 44. Muir A, Peck A, Clare-Salzler M, Song Y, Maclaren NK: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon γ transcription. J Clin Invest 95:628-634, 1995
45. 45. Zhang JZ, Davidson I, Eisenbarth G, Weiner HL: Suppression of diabetes in non obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252-10256, 1991
46. 46. Daniel D, Wegmann DR: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 93:956-60, 1996
47. 47. Keller RJ, Eisenbarth GS, Jackson RA: Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341:927-928, 1993
48. 48. Eisenbarth GS, Verge CF, Allen H, Rewers MJ: Perspectives in diabetes: The design of trials for prevention of IDDM. Diabetes 42:941-947, 1993
49. 49. Schloot N, Eisenbarth GS: Isohormonal therapy of endocrine autoimmunity. Immunol Today 16:289-294, 1995
50. 50. Carel JC, Bougnères PF, European Prediabetes Study Group: Treatment of prediabetic patients with insulin: Experience and future. Horm Res 45S1:44-47, 1996
51. 51. Daniel D, Gill RG, Schloot N, Wegmann D: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062, 1995
52. 52. Zekzer D, Wong FS, Wen L, Altieri M, Gurlo T, von Grafenstein H, Sherwin RS: Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the non obese diabetic mouse. Diabetes 46:1124-1132, 1997